A Crossover Study in the Treatment of Patients With COPD
NCT00462540
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Formoterol Fumurate inhalation solution 20 mcg
DRUG:
Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg
Sponsor
Dey